The presence of anti-centromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis

Author： Kampolis C. Plastiras S. C. Vlachoyiannopoulos P. G. Moyssakis I. Tzelepis G. E.

Publisher： Informa Healthcare

ISSN： 0300-9742

Source： Scandinavian Journal of Rheumatology, Vol.37, Iss.4, 2008-07, pp. : 278-283

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biomarkers in Systemic Sclerosis-Related Pulmonary Arterial Hypertension

Current Vascular Pharmacology, Vol. 9, Iss. 2, 2011-01 ,pp. : 213-219

Bentham Science Publishers

Access to resources Recommend Favorite

Anti‐centromere antibodies in patients with systemic lupus erythematosus

By Respaldiza N. Wichmann I. Ocaña C. Garcia F. J. Castillo M. J. Magariño M. I. Magariño R. Torres A. Sanchez J. Nuñez A.

Scandinavian Journal of Rheumatology, Vol. 35, Iss. 4, 2006-07 ,pp. : 290-294

Informa Healthcare

Access to resources Recommend Favorite

Clinical characteristics of patients with both anti-U1RNP and anti-centromere antibodies

By Takada K. Suzuki K. Matsumoto M. Okada M. Nakanishi T. Horikoshi H. Higuchi T. Ohsuzu F.

Scandinavian Journal of Rheumatology, Vol. 37, Iss. 5, 2008-01 ,pp. : 360-364

Informa Healthcare

Access to resources Recommend Favorite

Antifilaggrin antibodies in early rheumatoid arthritis may predict radiological progression.

By Forslind Kristina Vincent Christian Serre Guy Svensson Björn

Scandinavian Journal of Rheumatology, Vol. 30, Iss. 4, 2001-08 ,pp. : 221-224

Informa Healthcare

Access to resources Recommend Favorite

Pulmonary Arterial Hypertension in Systemic Sclerosis: Clinical Manifestations, Pathophysiology, Evaluation, and Management

By Ramirez Allan

Treatments in Respiratory Medicine, Vol. 3, Iss. 6, 2004-01 ,pp. : 339-352

Adis International

Access to resources Recommend Favorite